mmpc-logo mmpc-logo
twitter-logo    bluesky-logo
| Create Account | login
Experiment

Circulating glucose, insulin, sodium, and uric acid levels in C57BL/6NJ mice
treated with empagliflozin
Summary Data Summary
Investigator Manrique, Camila
Description Assess impact of SGLT2 inhibition on vascular aging.
Status Completed
Public Release 6/21/2023
Animal Age Measured In: week(s) post-natal (w)
Flags has-data-flagSame Strain
Data Analysis
TypeCount
Animals18
Experimental Conditions9
Catalog Items3
Curation Info (# flags)1
Phenotype Assays4
Phenotype Measurements72
Histology Images0
Publications0


Animals
Strain NameCommon NameFemalesMalesUnknown
C57BL/6NJ
0
18
0

Animals/Strains
Experimental Factors
 Categorical Values
Name / AbbreviationDescription

Experimental Factor: Drug Administered

 Empagliflozin
Empagliflozin is a SGLT2 class drug used in the treatment of type 2 diabetes
 Vehicle
Vehicle - Control

Experimental Factor: Drug Delivery Route

 PO
The drug was delivered orally

Experimental Factor: Drug Dose Units

 mg/kg/d
milligrams per kilograms per day

Experimental Factor: Experimental Group

 Control
This animal belongs to the control group for the experiment.
 Experiment
This animal belongs to experimental group that is homozygous for gene manipulations.

Experimental Factor: Feeding Group

 Fed
Animals are allowed to have food.

Experimental Factor: Mouse Diet

 LabDiet 5053
PicoLab Rodent Diet 20, 21.0% protein (Calories: 24.5% protein, 13.1% Fat, 62.4% Carbohydrate)

Experimental Factor: Tissue Source

 plasma (EDTA)
plasma (EDTA)
Experimental Factor Values


No documents found.

Menu

Home
Contact
About MMPC
Animal Husbandry
Tests Data
Search Data
Analysis
Clients
MMPC Centers

Newsletter

Interested in receiving MMPC News?
twitter-logo Mouse Phenotyping
@NationalMMPC



2017 National MMPC. All Rights Reserved.